We are very excited to celebrate our researchers and the awards and honors they are given!
Blog
Addiction & Substance Use Disorder, Anxiety, Conversations on Mental Health, Depression, Psychiatry | 1 comment | 14 June, 2022 | 0
Mass General researchers are testing how medical marijuana usage impacts mental health outcomes.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
While you may think that personal care products undergo the same regulatory scrutiny as food or medicine, there are few safeguards in place.
Witnessing the impact of health disparities as a student and Americorps volunteer in Alabama sparked an interest in public health & social justice.
Researchers from Mass General and colleagues created a model to simulate the health and financial benefits of reducing added sugars.